Inventor · disambiguated record
Kenneth W. Duncan
Also filed as: DUNCAN KENNETH · DUNCAN KENNETH W · DUNCAN KENNETH WILLIAM
52 granted patents·45 pending applications·1,052 citations·filing 2004–2025
99Inventor score
Top patents by PatentIndex Score
97 records- 0199US9365519B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Jun 14, 2016·34 cites·39 claims
- 0299US9206157B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2015·Granted Dec 8, 2015·28 cites·14 claims
- 0399US8993555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 31, 2015·50 cites·4 claims
- 0499US8962620B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Feb 24, 2015·31 cites·10 claims
- 0599US8598167B1Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Dec 3, 2013·34 cites·12 claims
- 0698US9675614B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jun 13, 2017·17 cites·23 claims
- 0798US9604930B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 28, 2017·21 cites·35 claims
- 0898US9549931B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 24, 2017·39 cites·21 claims
- 0998US9522152B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Dec 20, 2016·32 cites·8 claims
- 1098US9090562B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jul 28, 2015·51 cites·20 claims
- 1198US8940726B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jan 27, 2015·47 cites·22 claims
- 1298US8906900B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 9, 2014·44 cites·18 claims
- 1398US8765732B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2012·Granted Jul 1, 2014·66 cites·19 claims
- 1497US9718816B21-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Aug 1, 2017·25 cites·28 claims
- 1597US9365555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jun 14, 2016·37 cites·18 claims
- 1697US8410088B2Aryl- or heteroaryl-substituted benzene compoundsKUNTZ KEVIN W·Filed 2012·Granted Apr 2, 2013·96 cites·25 claims
- 1796US11052093B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2019·Granted Jul 6, 2021·7 cites·20 claims
- 1896US10155002B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Dec 18, 2018·16 cites·29 claims
- 1996US9855275B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Jan 2, 2018·18 cites·30 claims
- 2096US9732041B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Aug 15, 2017·17 cites·9 claims
- 2196US9388173B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jul 12, 2016·32 cites·23 claims
- 2296US9346761B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 24, 2016·38 cites·36 claims
- 2396US9266836B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Feb 23, 2016·35 cites·28 claims
- 2496US9221794B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 29, 2015·40 cites·17 claims
- 2595US10420775B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Sep 24, 2019·12 cites·20 claims
- 2695US9777008B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Oct 3, 2017·16 cites·22 claims
- 2795US9765068B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Sep 19, 2017·14 cites·27 claims
- 2895US9732072B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Aug 15, 2017·16 cites·19 claims
- 2995US9611257B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Apr 4, 2017·22 cites·16 claims
- 3094US10391089B2PRMT5 inhibitors and uses therofEPIZYME INC·Filed 2017·Granted Aug 27, 2019·5 cites·19 claims
- 3194US10307413B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Jun 4, 2019·5 cites·39 claims
- 3294US10273223B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2017·Granted Apr 30, 2019·5 cites·13 claims
- 3394US9637472B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted May 2, 2017·16 cites·19 claims
- 3493US10150758B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Dec 11, 2018·9 cites·7 claims
- 3593US9908887B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 6, 2018·14 cites·18 claims
- 3693US9745291B2PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereofEPIZYME INC·Filed 2013·Granted Aug 29, 2017·14 cites·13 claims
- 3792US12168015B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 17, 2024·0 cites·2 claims
- 3892US12161645B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 10, 2024·0 cites·10 claims
- 3992US9776972B2Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Oct 3, 2017·14 cites·31 claims
- 4091US12168016B2Aryl-OR heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 17, 2024·0 cites·12 claims
- 4191US2025170138A1Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Application pending·0 cites
- 4290US11672800B2Combination therapies with EHMT2 inhibitorsEPIZYME INC·Filed 2018·Granted Jun 13, 2023·5 cites·20 claims
- 4390US9376422B2Dihidropyridin-2-one benzamine compoundsKUNTZ KEVIN WAYNE·Filed 2012·Granted Jun 28, 2016·16 cites·19 claims
- 4486US10980794B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2019·Granted Apr 20, 2021·1 cites·20 claims
- 4585US12233065B2Inhibitors of RNA helicase DHX9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·0 cites·16 claims
- 4682US12162867B2Inhibitors of RNA helicase DHX9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Granted Dec 10, 2024·0 cites·16 claims
- 4780US2025145597A1Inhibitors of rna helicase dhx9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4878US7902361B2Pyrimidin-4-yl-3, 4-thione compounds and their use in therapyCYCLACEL LTD·Filed 2006·Granted Mar 8, 2011·7 cites·28 claims
- 4978US2021379076A1Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2021·Application pending·0 cites
- 5077US10118918B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Nov 6, 2018·2 cites·23 claims
Showing the top 50 of 97 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →